0001415889-13-001969.txt : 20131003
0001415889-13-001969.hdr.sgml : 20131003
20131003183552
ACCESSION NUMBER: 0001415889-13-001969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131001
FILED AS OF DATE: 20131003
DATE AS OF CHANGE: 20131003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aasen Thomas H
CENTRAL INDEX KEY: 0001291969
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 131135053
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BOULEVARD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4-10032013_031043.xml
X0306
4
2013-10-01
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001291969
Aasen Thomas H
11085 TORREYANA ROAD #100
SAN DIEGO
CA
92121
false
true
false
false
EXEC VP, CFO AND CBO
Common Stock
2013-10-01
4
M
0
5000
6.95
A
36585
D
Common Stock
2013-10-01
4
M
0
17500
1.55
A
54085
D
Common Stock
2013-10-01
5
G
0
30000
0
D
24085
D
Common Stock
2013-10-01
5
G
0
30000
0
A
30000
I
By Family Trust
Common Stock
2013-10-01
4
S
0
30000
27.8707
D
0
I
By Family Trust
Stock Option (right to buy)
6.95
2013-10-01
4
M
0
5000
0
D
2015-03-10
Common Stock
5000
26000
D
Stock Option (right to buy)
1.55
2013-10-01
4
M
0
17500
0
D
2020-03-11
Common Stock
17500
123471
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.75 to $28.00 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
25% of the shares subject to the Stock Option vested and became exercisable on March 11, 2006. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
/s/ Thomas H. Aasen
2013-10-03